Discontinued — last reported Q3 '23
Accenture Interest Paid increased by 814.1% to $114.98M in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 814.1%, from $12.58M to $114.98M. Over 2 years (FY 2021 to FY 2023), Interest Paid shows an upward trend with a 13.4% CAGR. This increase may warrant attention — for this metric, lower values are generally preferred.
An increase in interest paid relative to debt levels may signal rising borrowing costs or higher leverage, while a decrease may indicate debt reduction or refinancing at lower rates.
The total cash outflow for interest payments on debt obligations, typically disclosed as a supplemental item in the cash...
Essential for comparing the cost of capital and debt burden across peers in the pharmaceutical industry.
cf_interest_paid| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q4 '24 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $9.03M | $9.03M | $9.03M | $11.49M | $11.49M | $11.49M | $11.49M | $11.63M | $11.63M | $11.63M | $11.63M | $12.58M | $114.98M |
| QoQ Change | — | +0.0% | +0.0% | +27.2% | +0.0% | +0.0% | +0.0% | +1.2% | +0.0% | +0.0% | +0.0% | +8.2% | +814.1% |
| YoY Change | — | — | — | — | +27.2% | +27.2% | +27.2% | +1.2% | +1.2% | +1.2% | +1.2% | +8.2% | +814.1% |
We use cookies for analytics. See our Privacy and Cookie Policy.